Hypercalcemia is a condition where blood calcium levels exceed 10.5 mg/dL, often resulting from overactive parathyroid glands, certain cancers, or excessive vitamin D intake. It disrupts nerve signaling, muscle function, and kidney filtration.
Calcium is tightly regulated by the parathyroid glands, kidneys, bones, and intestines. When this system fails, calcium accumulates in the bloodstream. Most cases stem from either overproduction of parathyroid hormone (PTH) or abnormal calcium release from bone tissue due to disease.
According to the National Institutes of Health (NIH), primary hyperparathyroidism accounts for approximately 85% of hypercalcemia cases in outpatient settings. The condition typically presents with mild elevations in serum calcium and is often discovered incidentally during routine blood tests.
The body maintains calcium homeostasis through a feedback loop involving the parathyroid glands, kidneys, and bones. Parathyroid hormone (PTH) increases calcium absorption in the gut, promotes calcium reabsorption in the kidneys, and stimulates bone resorption when levels drop.
In hypercalcemia, this balance breaks down. PTH may be inappropriately high despite elevated calcium - a sign of primary hyperparathyroidism. Alternatively, calcium levels rise due to direct bone breakdown, such as in metastatic cancer or Paget's disease of bone.
Excess vitamin D enhances intestinal calcium absorption. A 2021 study in *The Journal of Clinical Endocrinology & Metabolism* found that patients with vitamin D levels above 150 ng/mL had higher rates of hypercalcemia, especially when combined with calcium supplementation.
Hypercalcemia arises from several distinct physiological pathways. The most frequent causes fall into three categories: parathyroid disorders, malignancies, and metabolic imbalances.
| Category | Specific Cause | Prevalence | Mechanism |
|---|---|---|---|
| Parathyroid | Primary hyperparathyroidism | ~85% of cases | Benign adenoma secretes excess PTH, increasing bone resorption and renal calcium reabsorption. |
| Cancer | Metastatic bone disease (e.g., breast, prostate) | ~10-15% | Tumor cells secrete PTH-related peptide (PTHrP), mimicking PTH action and causing bone destruction. |
| Metabolic | Vitamin D toxicity | <1% of cases | Excessive intake leads to uncontrolled calcium absorption in the intestines. |
| Medications | Thiazide diuretics | Rare, but clinically significant | Reduce calcium excretion in urine, leading to net retention. |
One non-obvious distinction: PTH levels are suppressed in malignancy-related hypercalcemia, whereas they remain elevated in primary hyperparathyroidism. This difference is critical for diagnosis.
A 62-year-old woman presented with fatigue, constipation, and confusion. Her labs showed serum calcium at 11.8 mg/dL and PTH at 120 pg/mL (normal range: 10-65). She had no history of cancer or vitamin D supplementation. Imaging revealed a 1.2 cm parathyroid adenoma. After surgical removal, her calcium normalized within 48 hours.
This case illustrates that hypercalcemia is not always symptomatic. Up to 50% of primary hyperparathyroidism cases are asymptomatic and detected via routine lab screening, per guidelines from the American Association of Clinical Endocrinologists (AACE).
Hypercalcemia is frequently mistaken for psychiatric symptoms. Fatigue, memory issues, and low mood are common complaints. In one study, 30% of patients with untreated hypercalcemia were initially diagnosed with depression before the correct cause was identified.
Screening for hypercalcemia is recommended in individuals with unexplained fatigue, kidney stones, or bone pain. The test is a serum calcium level, usually measured as total calcium or ionized calcium.
If elevated, confirm with corrected calcium (adjusted for albumin) and measure intact PTH. A high PTH with high calcium confirms primary hyperparathyroidism. A low or inappropriately normal PTH suggests malignancy or vitamin D toxicity.
I once saw a patient with severe fatigue and recurrent kidney stones. Initial labs showed calcium at 11.2 mg/dL. PTH was 140 pg/mL. Ultrasound revealed a single enlarged parathyroid gland. After parathyroidectomy, his calcium dropped to 9.2 mg/dL and his energy returned within two weeks.
Early detection prevents complications like nephrocalcinosis, cardiac arrhythmias, and cognitive decline. The NIH notes that untreated hypercalcemia increases mortality risk by 2.3 times over five years.
Understanding what causes hypercalcemia begins with recognizing that it is rarely a standalone issue. It signals an underlying disorder - whether hormonal, neoplastic, or nutritional. Identifying the root cause guides effective treatment and prevents long-term organ damage.